Clinical Trial Update: Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF Bronchiectasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety, tolerability, and efficacy of S-1226 in cystic fibrosis and bronchiectasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis
• Cystic Fibrosis

Drugs mentioned

• S-1226

Snippet

Sponsor: SolAeroMed Inc. | Conditions: Cystic Fibrosis, Bronchiectasis | Phase 2 | Status: UNKNOWN